PTCT - Company ID 0001070081
PTC THERAPEUTICS, INC. (PTCT) reported net income of $683.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $683.00M | +288.0% |
| FY 2024 | -$363.30M | +42.0% |
| FY 2023 | -$626.60M | -12.1% |
| FY 2022 | -$559.00M | -6.7% |
| FY 2021 | -$523.90M | -19.6% |
| FY 2020 | -$438.16M | -74.2% |
| FY 2019 | -$251.58M | -96.4% |
| FY 2018 | -$128.08M | -62.1% |
| FY 2017 |
PTC THERAPEUTICS, INC. (PTCT) reported net income of $683.00M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, PTC THERAPEUTICS, INC.'s net income grew from $30.90M to $683.00M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$79.00M |
| +44.4% |
| FY 2016 | -$142.11M | +16.6% |
| FY 2015 | -$170.45M | -81.8% |
| FY 2014 | -$93.75M | -81.8% |
| FY 2013 | -$51.57M | -96.6% |
| FY 2012 | -$26.23M | -184.9% |
| FY 2011 | $30.90M | - |